Press Releases Noxopharm Limited

Equities

NOX

AU000000NOX9

Market Closed - Australian S.E. Other stock markets 11:40:11 03/05/2024 am IST			5-day change	1st Jan Change
0.06 ^AUD	0.00%		-6.25%	-15.49%

04/04	Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	MT
27/02	Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Noxopharm talks partnership with Hudson Institute of Medical Research	12/23/12	AQ
Noxopharm : June 2022 Quarterly Activities Report and Appendix 4C	27/22/27	PU
Noxopharm : Corporate Presentation	07/22/07	PU
Noxopharm : March 2022 Quarterly Activities Report and Appendix 4C	28/22/28	PU
FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment	29/22/29	BU
Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles	08/22/08	BU
Noxopharm : Appendix 4D and Half Year 2022 Financial Report	21/22/21	PU
Noxopharm : Presents at H.C. Wainwright BioConnect Conference	10/22/10	PU
Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research	01/21/01	BU
Noxopharm : 2021 AGM Corporate Presentation	17/21/17	PU
Noxopharm Announces DARRT-2 Clinical Trial in U.S.	09/21/09	BU
Noxopharm : Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19	26/21/26	BU
Noxopharm : Phase I Clinical Trial Shows Anti-Inflammatory Response in COVID-19 Patients	25/21/25	BU
Noxopharm : Pre-clinical Study Confirms Survival Advantage of Combination LuPSMA Therapy in Prostate Cancer	12/21/12	BU
Noxopharm : Veyonda to Begin First-Line Sarcoma Treatment Testing	11/21/11	BU
Noxopharm : Clinical Data Shows Noxopharm’s Veyonda® May Prevent Cytokine Storm	27/21/27	BU
Noxopharm : Files Septic Shock Treatment Patent for Veyonda®	14/21/14	BU
Noxopharm : NOXCOVID Trial Advances to Final Stage	18/21/18	BU
Noxopharm : Independent Discovery Validates Noxopharm’s DARRT Cancer Therapy	03/20/03	BU
Noxopharm : Announces Pilot Study With Bristol Myers Squibb’s Product	12/20/12	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Noxopharm Limited

Equities

NOX

AU000000NOX9

Press Releases

Filters